Hasty Briefsbeta

  • #drug testing
  • #personalized medicine
  • #organoids
  • Organoids are small, lab-grown structures that mimic the functions of human organs, created from stem cells in a culture dish.
  • Hans Clevers, a professor of molecular genetics, has been researching organoids since the early 2000s, leading to advancements in drug testing and personalized medicine.
  • Organoids can be used to model diseases like cancer and cystic fibrosis, allowing for personalized drug testing and treatment plans.
  • The FDA has proposed reducing reliance on animal testing, partly due to the potential of organoids, though complete replacement is unlikely due to their simplicity.
  • Organoids are particularly promising for rare cancers and childhood cancers, where traditional treatments are limited or unknown.
  • Research is also exploring organoids for infectious diseases, such as Covid-19, to better understand how viruses affect different organs.
  • Despite their potential, widespread use of organoids in hospitals requires further development of automated systems for creation and testing.